Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASAPP: Low Dose Aspirin for Preeclampsia Prevention
NCT04070573Phase 3Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2019
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in preeclampsia, sponsored by Weill Cornell Medicine. Started Oct 2019; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT04070573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04070573.